Year: 2025
Type: editorial
Abstract: Genome editing technologies represented by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) have transformed biomedical research and therapeutic development [...].
Source: Cells
Authors: Jie Xu, Jifeng Zhang, Dongshan Yang
Institutions: University of Michigan, Michigan Medicine
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,258
OpenAlex ID: W7117128790
